Role of microtubules in glucose uptake by C6 glioma cells

被引:17
|
作者
Singh, SP
Gao, Y
Singh, LD
Kunapuli, SP
Ravindra, R
机构
[1] Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA 19140 USA
[2] Vet Affairs Med Ctr, Endocrine Metab Div, N Chicago, IL 60064 USA
[3] Finch Univ Hlth Sci Chicago Med Sch, N Chicago, IL 60064 USA
来源
PHARMACOLOGY & TOXICOLOGY | 1998年 / 83卷 / 02期
关键词
D O I
10.1111/j.1600-0773.1998.tb01448.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Drugs that influence tubulin function were used to investigate the role of microtubules in hexose uptake by C6 glioma cells. In C6 cells, colchicine and vinblastine (which inhibit tubulin polymerization) inhibited radioactive [H-3]2-deoxy-D-glucose uptake by about 30%. Paclitaxel (which promotes tubulin polymerization) stimulated hexose uptake by about 25%. To further demonstrate that microtubules play a role in hexose uptake, C6 cells were transfected with GLUT1 cDNA and then challenged with 100 nM paclitaxel. In GLUT1- transfected cells paclitaxel stimulated 2-deoxy-D-glucose uptake by about 35%. To study the role of tubulin in agonist-stimulated hexose uptake, the effect of colchicine on carbachol-induced uptake was next examined. Hexose uptake was increased with carbachol in concentration-dependent manner which was abolished by pretreatment with colchicine. To examine the specificity of the inhibitory effect of colchicine on G protein-mediated signal transduction pathway the influence of colchicine on insulin (which acts via tyrosine kinase pathway) stimulation of 2-deoxy-D-glucose uptake was investigated. Hexose uptake was increased by insulin in a concentration-dependent manner which was unaffected by pretreatment with colchicine. These results suggest that microtubules are involved in basal and carbachol-stimulated glucose uptake by C6 cells.
引用
收藏
页码:83 / 89
页数:7
相关论文
共 50 条
  • [21] Glucose and glutamine metabolism in C6 glioma cells studied by carbon 13 NMR
    Portais, JC
    Voisin, P
    Merle, M
    Canioni, P
    BIOCHIMIE, 1996, 78 (03) : 155 - 164
  • [22] The increase in gap junctional communication decreases the rate of glucose uptake in C6 glioma cells by releasing hexokinase from mitochondria
    Sánchez-Alvarez, R
    Tabernero, A
    Medina, JM
    BRAIN RESEARCH, 2005, 1039 (1-2) : 189 - 198
  • [23] Role of glucose-6-phosphate dehydrogenase in regulation of inducible nitric oxide gene expression in C6 rat glioma cells
    Wen, JS
    Im, YB
    Singh, I
    FASEB JOURNAL, 2001, 15 (04): : A198 - A198
  • [24] Intranuclear microtubules are hallmarks of an unusual form of cell death in cisplatin-treated C6 glioma cells
    Krajcí, D
    Mares, V
    Lisá, V
    Bottone, MG
    Pellicciari, C
    HISTOCHEMISTRY AND CELL BIOLOGY, 2006, 125 (1-2) : 183 - 191
  • [25] Synthesis and accumulation of alpha B crystallin in C6 glioma cells is induced by agents that promote the disassembly of microtubules
    Kato, K
    Ito, H
    Inaguma, Y
    Okamoto, K
    Saga, S
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (43) : 26989 - 26994
  • [26] Identification of caveolae and caveolin in C6 glioma cells
    Silva, WI
    Maldonado, HM
    Lisanti, MP
    DeVellis, J
    Chompré, G
    Mayol, N
    Ortiz, M
    Velázquez, G
    Maldonado, A
    JOURNAL OF NEUROCHEMISTRY, 1999, 72 : S72 - S72
  • [27] Cytoskeleton and Nucleotide Signaling in Glioma C6 Cells
    Klopocka, Wanda
    Korczynski, Jaroslaw
    Pomorski, Pawel
    GLIOMA SIGNALING, 2013, 986 : 103 - 119
  • [28] Cytoskeleton and Nucleotide Signaling in Glioma C6 Cells
    Klopocka, Wanda
    Korczynski, Jaroslaw
    Pomorski, Pawel
    GLIOMA SIGNALING, 2ND EDITION, 2020, 1202 : 109 - 128
  • [29] Intranuclear microtubules are hallmarks of an unusual form of cell death in cisplatin-treated C6 glioma cells
    D. Krajčí
    V. Mareš
    V. Lisá
    M.G. Bottone
    C. Pellicciari
    Histochemistry and Cell Biology, 2006, 125 : 183 - 191
  • [30] NO-mediated chemoresistance in C6 glioma cells
    Yang, DI
    Yin, JH
    Mishra, S
    Mishra, RAJ
    Hsu, CY
    NITRIC OXIDE: NOVEL ACTIONS, DELETERIOUS EFFECTS AND CLINICAL POTENTIAL, 2002, 962 : 8 - 17